TBK1 and renal cell carcinoma: TBK1 (TANK-binding kinase 1), known for its role in innate immunity and inflammation (Xu et al., 2021), has been linked to oncogenic processes when dysregulated (Wang et al., 2024), potentially contributing to immune evasion and chronic inflammation in RCC.